Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | VCAM1 | P19320 | 11/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.47 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.47 |
| ▸ | KDM1A | O60341 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29707970 | 1.00 | VCAM1 (0.56) | VCAM1ALDH1A1KDM4EPOLBMAPT | |
| SCHEMBL30623363 | 0.86 | TSHR (0.53) | VCAM1ALDH1A1KDM4EPOLBMAPT | |
| SCHEMBL18766395 | 0.86 | TSHR (0.53) | VCAM1ALDH1A1KDM4EPOLBMAPT | |
| SCHEMBL10270605 | 0.85 | TSHR (0.58) | VCAM1ALDH1A1KDM4EPOLBMAPT | |
| SCHEMBL4520586 | 0.83 | VCAM1 (0.53) | VCAM1ALDH1A1KDM4EPOLBKDM1A | |
| SCHEMBL515466 | 0.82 | MAPT (0.54) | ALDH1A1POLBMAPTSMN1; SMN2 | |
| SCHEMBL811582 | 0.81 | VCAM1 (0.54) | VCAM1ALDH1A1KDM4EPOLB | |
| SCHEMBL18653119 | 0.81 | VCAM1 (0.51) | VCAM1ALDH1A1KDM4EPOLBMAPT | |
| SCHEMBL627966 | 0.81 | VCAM1 (0.51) | VCAM1ALDH1A1KDM4EPOLBKDM1A | |
| SCHEMBL671271 | 0.81 | VCAM1 (0.54) | VCAM1ALDH1A1KDM4EPOLBMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 185 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109406609-B | Electrochemical method for on-line analysis of nitro reduction reaction | 联化科技股份有限公司 | 2021-06-04 | — | — | CN | claimed |
| CN-106045802-A | Preparation method of alicyclic and aromatic-aliphatic chloroformate | 长江大学 | 2016-10-26 | — | — | CN | claimed |
| EP-4630114-A1 | NEW CYANOPYRIDINE KHK INHIBITOR COMPOUNDS | Boehringer Ingelheim International GmbH (DE) | 2025-10-15 | — | — | EP | disclosed |
| US-20240343726-A1 | PYRROLOPYRIDINE-3- AND 4-CARBOXAMIDE COMPOSITIONS AND METHODS FOR CELLULAR PROLIFERATION | THE ROCKEFELLER UNIVERSITY (US) | 2024-10-17 | — | — | US | disclosed |
| EP-3962915-B1 | SELECTIVE LIGANDS OF HUMAN CONSTITUTIVE ANDROSTANE RECEPTOR | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR V V I (CZ) | 2024-09-04 | — | — | EP | disclosed |
| US-20240208934-A1 | ULK1/2 INHIBITORS AND THEIR USE THEREOF | LIFEARC (GB) | 2024-06-27 | — | — | US | disclosed |
| WO-2024121183-A1 | NEW CYANOPYRIDINE KHK INHIBITOR COMPOUNDS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2024-06-13 | — | — | WO | disclosed |
| EP-4380562-A1 | PYRROLOPYRIDINE-3- AND 4-CARBOXAMIDE COMPOSITIONS AND METHODS FOR CELLULAR PROLIFERATION | The Rockefeller University (US) | 2024-06-12 | — | — | EP | disclosed |
| EP-4320121-A2 | 2,4-DIAMINOPYRIMIDINE DERIVATIVES AS ULK1/2 INHIBITORS AND THEIR USE THEREOF | LifeArc (GB) | 2024-02-14 | — | — | EP | disclosed |
| CN-117545751-A | 2, 4-diaminopyrimidine derivatives as ULK1/2 inhibitors and their use | 生命爱科 | 2024-02-09 | — | — | CN | disclosed |
| US-20230303570-A1 | KINASE INHIBITORS AND USES THEREOF | ABM THERAPEUTICS CORP (US) | 2023-09-28 | — | — | US | disclosed |
| US-4215219-A | CHELATING AGENTS | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 1980-07-29 | — | — | US | disclosed |
| US-4196125-A | VIRICIDES | ELI LILLY AND COMPANY (US) | 1980-04-01 | — | — | US | disclosed |
| US-4174454-A | VIRICIDES | ELI LILLY AND COMPANY (US) | 1979-11-13 | — | — | US | disclosed |
| US-4150028-A | Antiviral thiazolinyl benzimidazoles | ELI LILLY AND COMPANY (US) | 1979-04-17 | — | — | US | disclosed |
| US-4118573-A | ANTIVIRAL AGENTS | ELI LILLY AND COMPANY (US) | 1978-10-03 | — | — | US | disclosed |
| US-4118742-A | VIRICIDES | ELI LILLY AND COMPANY (US) | 1978-10-03 | — | — | US | disclosed |
| US-4085261-A | CHELATING AGENT WITH A STYRENE POLYMER BACKBONE | YEDA RESEARCH AND DEVELOPMENT CO., LTD. (IL) | 1978-04-18 | — | — | US | disclosed |
| US-4018790-A | VIRICIDES | ELI LILLY AND COMPANY (US) | 1977-04-19 | — | — | US | disclosed |
| US-3974110-A | Modification of polystyrene by Friedel-Crafts reaction with substituted halo ethyl benzenes and haloethylphenols to make supports for solid phase peptide synthesis | YEDA RESEARCH & DEVELOPMENT CO. LTD. (IL) | 1976-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230303570-A1 | KINASE INHIBITORS AND USES THEREOF | ERBB2, ERBB3, ERBB4 | VCAM1 1724/4885ALDH1A1 1859/4885KDM4E 1096/4885 |
| US-20240343726-A1 | PYRROLOPYRIDINE-3- AND 4-CARBOXAMIDE COMPOSITIONS AND METHODS FOR CELLULAR PROLIFERATION | LATS1, LATS2, YAP1 | VCAM1 4597/4885ALDH1A1 3828/4885KDM4E 766/4885 |
| US-20240208934-A1 | ULK1/2 INHIBITORS AND THEIR USE THEREOF | ULK1, ULK2, ULK3 | VCAM1 3808/4885ALDH1A1 3376/4885KDM4E 1915/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.